Tango Therapeutics, Inc. [TNGX] has reported fiscal Q1 profit of $28 million.
On a per-share basis, the DE based company said its diluted earnings are $0.32.
The Pharmaceutical Preparations firm posted revenue of $5.80 million in this period.
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.